Literature DB >> 29453555

Evaluation of the effect of hyperthermia and electron radiation on prostate cancer stem cells.

Zhila Rajaee1, Samideh Khoei2, Seied Rabi Mahdavi1, Marzieh Ebrahimi3, Sakine Shirvalilou1, Alireza Mahdavian4.   

Abstract

The aim of this study was to investigate the effect of hyperthermia, 6 MeV electron radiation and combination of these treatments on cancer cell line DU145 in both monolayer culture and spheroids enriched for prostate cancer stem cells (CSCs). Flowcytometric analysis of the expression of molecular markers CD133+/CD44+ was carried out to determine the prostate CSCs in cell line DU145 grown as spheroids in serum-free medium. Following monolayer and spheroid culture, DU145 cells were treated with different doses of hyperthermia, electron beam and combination of them. The survival and self-renewing of the cells were evaluated by colony formation assay (CFA) and spheroid formation assay (SFA). Flowcytometry results indicated that the percentage of CD133+/CD44+ cells in spheroid culture was 13.9-fold higher than in the monolayer culture. The SFA showed significant difference between monolayer and spheroid culture for radiation treatment (6 Gy) and hyperthermia (60 and 90 min). The CFA showed significantly enhanced radiosensitivity in DU145 cells grown as monolayer as compared to spheroids, but no effect of hyperthermia. In contrast, for the combination of radiation and hyperthermia the results of CFA and SFA showed a reduced survival fraction in both cultures, with larger effects in monolayer than in spheroid culture. Thus, hyperthermia may be a promising approach in prostate cancer treatment that enhances the cytotoxic effect of electron radiation. Furthermore, determination and characterization of radioresistance and thermoresistance of CSCs in the prostate tumor is the key to develop more efficient therapeutic strategies.

Entities:  

Keywords:  Cancer stem cells; DU145 cell line; Electron radiation; Hyperthermia; Prostate cancer

Mesh:

Year:  2018        PMID: 29453555     DOI: 10.1007/s00411-018-0733-x

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  49 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

2.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Authors:  Axel Heidenreich; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Nicolas Mottet; Hans-Peter Schmid; Theo van der Kwast; Thomas Wiegel; Filliberto Zattoni
Journal:  Eur Urol       Date:  2010-10-28       Impact factor: 20.096

3.  Heating cancer stem cells to reduce tumor relapse.

Authors:  Pier Giuseppe Pelicci; Paola Dalton; Roberto Orecchia
Journal:  Breast Cancer Res       Date:  2011-05-06       Impact factor: 6.466

Review 4.  Cancer stem cells in human gastrointestinal cancers.

Authors:  Naotsugu Haraguchi; Hiroshi Inoue; Fumiaki Tanaka; Koshi Mimori; Tohru Utsunomiya; Atsushi Sasaki; Masaki Mori
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

Review 5.  Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization.

Authors:  Virginia Tirino; Vincenzo Desiderio; Francesca Paino; Alfredo De Rosa; Federica Papaccio; Marcella La Noce; Luigi Laino; Francesco De Francesco; Gianpaolo Papaccio
Journal:  FASEB J       Date:  2012-09-28       Impact factor: 5.191

6.  Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.

Authors:  Linlin Zhang; Min Jiao; Lei Li; Dapeng Wu; Kaijie Wu; Xiang Li; Guodong Zhu; Qiang Dang; Xinyang Wang; Jer-Tsong Hsieh; Dalin He
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

7.  Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution.

Authors:  Manfred Johannsen; Uwe Gneveckow; Burghard Thiesen; Kasra Taymoorian; Chie Hee Cho; Norbert Waldöfner; Regina Scholz; Andreas Jordan; Stefan A Loening; Peter Wust
Journal:  Eur Urol       Date:  2006-11-17       Impact factor: 20.096

8.  Quality of life of men with biochemical recurrence of prostate cancer.

Authors:  Steven C Ames; Winston W Tan; Gretchen E Ames; Ronald L Stone; Thomas D Rizzo; Michael G Heckman; Julia E Crook; Matthew M Clark; Teresa A Rummans; Chudley E Werch
Journal:  J Psychosoc Oncol       Date:  2008

9.  Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.

Authors:  Lei Wang; Xing Huang; Xinmin Zheng; Xinghuan Wang; Shiwen Li; Lin Zhang; Zhonghua Yang; Zhiping Xia
Journal:  Int J Biol Sci       Date:  2013-05-15       Impact factor: 6.580

10.  Action of x-rays on mammalian cells.

Authors:  T T PUCK; P I MARCUS
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

View more
  3 in total

1.  3D tumour spheroids for the prediction of the effects of radiation and hyperthermia treatments.

Authors:  Sarah C Brüningk; Ian Rivens; Carol Box; Uwe Oelfke; Gail Ter Haar
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

2.  Enhancement of Radio-Thermo-Sensitivity of 5-Iodo-2-Deoxyuridine-Loaded Polymeric-Coated Magnetic Nanoparticles Triggers Apoptosis in U87MG Human Glioblastoma Cancer Cell Line.

Authors:  Samideh Khoei; Vahid Hosseini; Mehdi Hosseini; Sepideh Khoee; Sakine Shirvalilou; Seied Rabi Mahdavi; Jalil Pirayesh Islamian
Journal:  Cell Mol Bioeng       Date:  2021-06-18       Impact factor: 3.337

3.  A Novel Framework for the Optimization of Simultaneous ThermoBrachyTherapy.

Authors:  Ioannis Androulakis; Rob M C Mestrom; Miranda E M C Christianen; Inger-Karine K Kolkman-Deurloo; Gerard C van Rhoon
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.